[Method comparison between two hemostasis analyzers: STA R Max3 and Cobas t 511].

Sophie Melicine, Nazanine Bayani, Juliette Vo Xuan, Maeva Deleray, Rym Chouk, Rita Creidy, Bassem Khazem
{"title":"[Method comparison between two hemostasis analyzers: STA R Max<sup>3</sup> and Cobas t 511].","authors":"Sophie Melicine, Nazanine Bayani, Juliette Vo Xuan, Maeva Deleray, Rym Chouk, Rita Creidy, Bassem Khazem","doi":"10.1684/abc.2024.1904","DOIUrl":null,"url":null,"abstract":"<p><p>The STA R Max3 (Stago, France) and Cobas t511 (Roche Diagnostics, Germany) are two automated hemostasis analysers that can be used to perform a wide range of tests. The STA R Max3 uses a mechanical clot detection system to measure coagulation times, while the Cobas t511 uses optical detection. The aim of this study was to compare the analytical performance of these two analysers using fresh plasma samples with or without a risk of interference due to hemolysis or lipemia. For plasma samples without interference, acceptable agreement was observed for prothrombin time (PT) (n = 55), activated partial thromboplastin time (APTT) (n = 56), fibrinogen (n = 56) and factor II (n = 43) with R² of 0.907, 0.963, 0.979 and 0.968 respectively. For factor V (n = 43) and D-dimers (n = 45), agreement was less acceptable, with respective R² of 0.756 and 0.887, but with no clinical impact. For hemolysed samples, acceptable results were observed for PT, fibrinogen and D-dimers, but three results were clinically discordant for APTT, and STA R Max3 offered greater robustness for processing highly lipemic samples.</p>","PeriodicalId":93870,"journal":{"name":"Annales de biologie clinique","volume":"82 4","pages":"387-403"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales de biologie clinique","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1684/abc.2024.1904","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The STA R Max3 (Stago, France) and Cobas t511 (Roche Diagnostics, Germany) are two automated hemostasis analysers that can be used to perform a wide range of tests. The STA R Max3 uses a mechanical clot detection system to measure coagulation times, while the Cobas t511 uses optical detection. The aim of this study was to compare the analytical performance of these two analysers using fresh plasma samples with or without a risk of interference due to hemolysis or lipemia. For plasma samples without interference, acceptable agreement was observed for prothrombin time (PT) (n = 55), activated partial thromboplastin time (APTT) (n = 56), fibrinogen (n = 56) and factor II (n = 43) with R² of 0.907, 0.963, 0.979 and 0.968 respectively. For factor V (n = 43) and D-dimers (n = 45), agreement was less acceptable, with respective R² of 0.756 and 0.887, but with no clinical impact. For hemolysed samples, acceptable results were observed for PT, fibrinogen and D-dimers, but three results were clinically discordant for APTT, and STA R Max3 offered greater robustness for processing highly lipemic samples.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[两种止血分析仪的方法比较:STA R Max3 和 Cobas t 511]。
STA R Max3(法国 Stago 公司)和 Cobas t511(德国罗氏诊断公司)是两款自动止血分析仪,可用于进行多种检测。STA R Max3 使用机械血块检测系统测量凝血时间,而 Cobas t511 使用光学检测系统。本研究的目的是比较这两种分析仪在使用有或没有溶血或脂血干扰风险的新鲜血浆样本时的分析性能。在无干扰的血浆样本中,凝血酶原时间(PT)(n = 55)、活化部分凝血活酶时间(APTT)(n = 56)、纤维蛋白原(n = 56)和因子 II(n = 43)的 R² 分别为 0.907、0.963、0.979 和 0.968,一致性可接受。因子 V(n = 43)和 D-二聚体(n = 45)的一致性较差,R² 分别为 0.756 和 0.887,但对临床没有影响。对于溶血样本,PT、纤维蛋白原和 D-二聚体的结果均可接受,但 APTT 的三个结果在临床上不一致,STA R Max3 在处理高脂血症样本时具有更强的稳健性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Complementarity between Bayesian Internal Quality Control results management and External Quality Assessment bivariate z-score analysis: application to a concrete case study. [Can TDABC (Time-Driven Activity-Based Costing) help the NOVO hospital's medical biology laboratory to value the appropriate prescription? - Role of the biologist in reducing healthcare costs]. [Clinical associations of anti-Jo1 antibodies in a Moroccan population]. [Clinical-biological approaches to the spectrophotometric detection of oxyhemoglobin and bilirubin in CSF in the management of aneurysmal subarachnoid hemorrhage]. [Evaluation of the CellaVision® DM-1200 system for detecting and quantifying schistocytes].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1